Physician profile
Daniel Groves
NPI 1124445168
$1,100.81
in general payments reported to CMS, 2019-2025
23 companies · $41.29 in 2025
The $41.29 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $267 · 2021: $21.46 · 2023: $217 · 2024: $131 · 2025: $41.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $171.47 | 2019-2020 | |
| Axonics, INC. | $112.63 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $107.87 | 2019-2023 | Lithovue |
| Janssen Scientific Affairs, LLC | $105.92 | 2019 | |
| Medtronic, INC. | $103.50 | 2023-2025 | Interstim |
| Sun Pharmaceutical Industries INC. | $72.10 | 2023 | Absorica Ld, Winlevi |
| Medtronic USA, INC. | $57.27 | 2019-2020 | |
| Dentsply Ih Ab | $41.67 | 2024 | Lofric |
| Janssen Biotech, INC. | $40.47 | 2019-2024 | Erleada, Akeega |
| Endo Pharmaceuticals INC. | $39.55 | 2023 | Aveed, Xiaflex |
| Neotract INC. | $37.70 | 2020 | |
| Metuchen Pharmaceuticals | $25.53 | 2019-2020 | |
| Teleflex LLC | $25.40 | 2024 | Urolift |
| Blue Earth Diagnostics | $23.88 | 2020 | |
| Abbvie INC. | $21.66 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21.46 | 2021 | |
| Dornier Medtech America, INC | $16.08 | 2019 | |
| Coloplast Corp | $15.17 | 2020 | |
| Rochester Medical Corporation | $15.01 | 2019 | |
| Olympus America INC. | $13.21 | 2020 | |
| Pfizer INC. | $12.81 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.